CheckMan Stock Market Overview

Philadelphia, Pennsylvania--(Newsfile Corp. - September 8, 2026) - Berger Montague, a leading national plaintiffs' law firm, announces a class action lawsuit against Pentair plc (NYSE: PNR) ("Pentair" or the "Company") on behalf of investors who purchased or acquired Pentair securities during the period from March 11, 2025 through July 14, 2026 (the "Class Period"). Q&A What is this lawsuit about?

Salesforce just posted an earnings beat that sent the stock surging 34%, but the source of that surprise raises questions every investor should answer before buying in at these levels.

CAPL and GLP bring distinct strengths in income, scale, leverage and valuation, setting up a closer comparison for energy MLP investors.

CRTO, DIN and LNWO have been added to the Zacks Rank #5 (Strong Sell) List on September 8, 2026.

Three dividend growth stocks are here to offer income and growth potential as interest rates may stay higher for longer.

Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.

The Standard & Poor's 500 Index (SPX-7,718.60) May through July range has turned into an August-September consolidation, with roughly 200 SPX points separating the low and high ends of the ranges in both cases.

STAMFORD, Conn., Sept. 8, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today released a fact sheet addressing a number of inaccurate and misleading statements made by Aurora Cannabis Inc. ("Aurora") in connection with Curaleaf's proposal to acquire Aurora.

A deepened High-NA EUV collaboration is lifting Intel (NASDAQ:INTC | INTC Price Prediction) and ASML Holding (NASDAQ:ASML) in Tuesday morning trading, with the semiconductor equipment story cutting against a softer market backdrop.

Sandoz CEO Richard Saynor warned U.S. patients could ultimately bear the cost of threatened tariffs on imported generic drugs. Saynor said manufacturers facing steep tariffs could be forced to raise prices or stop supplying some medicines.